- Fee assured
- Verified this account
This healthcare professional is currently treating patients. Please speak to them to find out more about their availability.
Last updated: 12 Nov 2020
Dr Peter Dickinson graduated from the University of Nottingham Medical School in 2004 and undertook his specialist Clinical Oncology Training in Nottingham, followed by a radiotherapy research fellowship at the Christie Hospital in Manchester. He was appointed consultant at Leeds Teaching Hospitals Trust in 2013. He is Radiotherapy Clinical Lead at Leeds Teaching Hospitals.
Dr Dickinson specialises in the treatment of lung cancer and the use of stereotactic radiotherapy to treat metastatic cancer. He is a key member of the Stereotactic Ablative Radiotherapy (SABR) team at Leeds Teaching Hospital Trust and is lead clinician for the oligometastatic radiotherapy programme, which focuses upon the treatment of early-stage metastasis.
He has an active interest in clinical research and has been the Principal or Co-Investigator for numerous national and international clinical trials investigating the use of new radiotherapy techniques as well as systemic therapy. He sits on the Trial Management Group for a national radiotherapy study. Dr Dickinson has also published a number of papers on radiotherapy, chemotherapy and basic science
Areas of interest
Lung cancer; Stereotactic radiotherapy for oligometastatic disease
- Jayne Bell
- NOVA Healthcare Level 4 Bexley Wing St James's University Hospital Beckett Street Leeds LS9 7TF
- 0113 206 8699
- 0113 206 7438
Current NHS consultant posts held
Consultant Clinical Oncologist and Radiotherapy Clinical Lead, Leeds Teaching Hospitals NHS Trust
- BMedSci University of Nottingham 2002
- BM BS University of Nottingham 2004
- MRCP The Royal College of Physicians 2007
- MSc (Oncology) The University of Nottingham 2010
- FRCR The Royal College of Radiologists 2011
Reference number 6101671
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.